SBC — SBC Medical group Income Statement
0.000.00%
Last trade - 00:00- $326.19m
- $220.21m
- $173.61m
Annual income statement for SBC Medical group, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS/A | PROSPECTUS/A | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 174 | 194 | 205 | 174 |
| Cost of Revenue | ||||
| Gross Profit | 115 | 137 | 156 | 127 |
| Selling / General / Administrative Expenses | ||||
| Unusual Expense / Income | ||||
| Total Operating Expenses | 154 | 123 | 131 | 97.4 |
| Operating Profit | 20.1 | 70.7 | 74.1 | 76.2 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | 23.7 | 73.6 | 73.5 | 82.1 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | 5.55 | 38.6 | 46.7 | 51 |
| Minority Interest | ||||
| Net Income Before Extraordinary Items | ||||
| Net Income | 6.32 | 39.4 | 46.6 | 51 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | 6.32 | 39.4 | 46.6 | 51 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | 0.047 | 0.34 | 0.551 | 0.424 |
| Dividends per Share |